impact factor, citescore
logo
 

Clinical aspects

 

The prevalence and relevance of traditional cardiovascular risk factors in primary Sjögren’s syndrome


1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11

 

  1. Rheumatology Unit, University of Perugia, Italy.
  2. Rheumatology Unit, University of Perugia, Italy.
  3. Rheumatology Unit, University of Perugia, Italy.
  4. Rheumatology Unit, University of Perugia, Italy.
  5. Rheumatology Unit, University of Perugia, Italy.
  6. Rheumatology Unit, University of Perugia, Italy.
  7. Rheumatology Unit, University of Perugia, Italy.
  8. Rheumatology Unit, University of Perugia, Italy.
  9. Rheumatology Unit, University of Perugia, Italy.
  10. Rheumatology Unit, University of Perugia, Italy.
  11. Rheumatology Unit, University of Perugia, Italy. roberto.gerli@unipg.it

CER11370
2018 Vol.36, N°3 ,Suppl.112
PI 0113, PF 0120
Clinical aspects

Free to view
(click on article PDF icon to read the article)

PMID: 29998823 [PubMed]

Received: 01/05/2018
Accepted : 17/05/2018
In Press: 30/05/2018
Published: 14/08/2018

Abstract

Accelerated atherosclerosis is a distinct feature of some inflammatory and autoimmune disorders and several specific autoimmune mechanisms and persistent inflammation have been identified to exert a pivotal role in precocious atherosclerotic damage in these disorders. Although increased atherosclerotic risk has been well established in some rheumatic autoimmune systemic diseases, such as systemic lupus erythematosus and rheumatoid arthritis, reliable data regarding the prevalence and pathogenetic mechanisms associated with increased atherosclerotic damage in primary Sjögren’s syndrome are scarse. Indeed, primary Sjögren’s syndrome is an autoimmune disorder characterised by chronic inflammation and autoimmune dysregulation that shares many pathogenic mechanisms and clinical features with systemic lupus erythematosus and rheumatoid arthitis. Higher prevalence of subclinical atherosclerosis has been observed in primary Sjögren’s syndrome patients and recent population-based studies demonstrated an increased risk of cardiovascular events in these patients in comparison to general population. Among mechanisms associated with atherosclerotic damage, the prevalence and the role of traditional cardiovascular risk factors have been poorly investigated. In particular, the issue of whether the presence of these cardiovascular risk factors is associated with an increased risk of cardiovascular events needs to be further explored.

Rheumatology Article